Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-089090
Filing Date
2025-06-23
Accepted
2025-06-23 17:32:12
Documents
25
Period of Report
2025-07-24

Document Format Files

Seq Description Document Type Size
1 PRE 14A apvo-20250623.htm   iXBRL PRE 14A 1540200
2 GRAPHIC img136410189_0.jpg GRAPHIC 45134
3 GRAPHIC img136410189_1.jpg GRAPHIC 45134
4 GRAPHIC img136410189_2.jpg GRAPHIC 45134
5 GRAPHIC img136410189_3.jpg GRAPHIC 45134
6 GRAPHIC img136410189_4.jpg GRAPHIC 45134
7 GRAPHIC img136410189_5.jpg GRAPHIC 47859
8 GRAPHIC img136410189_6.jpg GRAPHIC 45134
9 GRAPHIC img136410189_7.jpg GRAPHIC 45134
10 GRAPHIC img136410189_8.jpg GRAPHIC 45134
11 GRAPHIC img136410189_9.jpg GRAPHIC 353686
12 GRAPHIC img136410189_10.jpg GRAPHIC 65121
13 GRAPHIC img136410189_11.jpg GRAPHIC 204521
  Complete submission text file 0000950170-25-089090.txt   4420674

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20250623.xsd EX-101.SCH 7954
27 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20250623_htm.xml XML 203049
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37746 | Film No.: 251066029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)